Kenvue Stock And 2 Consumer Staples Picks For Defensive Dividend Investors

With real wages squeezed by stubborn inflation and household budgets under pressure, investors are paying closer attention to companies tied to everyday essentials. Consumer staples stocks in our U.S. screener sit right in the middle of this story, where price sensitivity, volume trends and cost control all matter. This article walks through 3 stocks that appear positively exposed to this backdrop and explains why each might deserve a place on your watchlist.

The stocks covered below are only a sample from this idea, and the full filter surfaced 17 more U.S. consumer staples companies with similarly interesting stories around everyday products and income potential that are not discussed here. To see the wider opportunity set, head straight into the U.S. Consumer Staples Stocks screener to identify, compare, and analyze the consumer staples stocks that best fit your own conviction.

Kenvue (KVUE)

Kenvue is a global consumer health company behind everyday brands such as Tylenol, Benadryl, Neutrogena and Listerine, selling over the counter medicines, skincare and personal care products that many households treat as essentials. The business leans most heavily on its Self Care segment, which generates about US$6.4b in revenue, followed by Essential Health at roughly US$4.7b and Skin Health and Beauty at about US$4.3b. The stock is a large cap with a market value around US$36.6b.

Investors looking for resilience while real wages are under pressure may find Kenvue worth a closer look. The company sells products that tend to stay in the basket even when consumers cut back elsewhere, and it has been working to protect margins as inflation affects energy and labor costs. Earnings momentum, a higher dividend and analyst expectations for gradually improving profitability sit alongside real risks, including high leverage and ongoing Tylenol litigation. The mix of everyday demand, cost discipline and legal and balance sheet questions creates a nuanced setup that rewards deeper research into how sustainable Kenvue's current trajectory is.

Everyday brands, rising dividends and shifting profitability expectations make Kenvue look like more than a simple “defensive” play, yet its balance sheet and Tylenol overhang still matter. Get the full story in the 3 key rewards and 2 important warning signs

Build your own everyday essentials shortlist

Kenvue and the other two stocks in this article all came from a single screener, but the real edge comes from shaping filters around what matters most to you. Use our flexible Screener to mix metrics like valuation, balance sheet strength, risks and dividends, or jump straight into our curated Investing Ideas for ready made starting points.

Dole (DOLE)

Dole is one of the largest global producers and distributors of fresh fruits and vegetables, supplying bananas, pineapples, berries and a wide range of other produce to retailers and foodservice customers under the DOLE brand. Revenue is spread across Fresh Fruit at about US$3.7b, Diversified Fresh Produce EMEA at roughly US$4.2b and Diversified Fresh Produce Americas and ROW at around US$1.8b. The stock is a mid cap with a market value of about US$1.2b.

Dole sits in a favorable position for this macro backdrop. When real wages stall and consumers cut back on discretionary treats, they still tend to keep buying affordable staples like fresh fruit and vegetables, which recent management commentary supports. At the same time, investors need to weigh that defensive demand against thin net margins around 0.7%, leverage that is not comfortably covered by operating cash flow and recent earnings misses tied to sourcing and transport costs. The valuation signals and dividend, combined with efforts to improve margins and simplify the portfolio, make Dole a stock where patient investors may see a lot more than just bananas and pineapples if they look a little closer.

Dole’s thin margins and global reach can make the story look ordinary at first glance. Yet the mix of staples demand, leverage and cash flow tells a different story inside the analysis report for Dole

MGP Ingredients (MGPI)

MGP Ingredients is a small US$393 million spirits and specialty ingredients company that sits at the crossroads of everyday drinking habits and packaged food trends. It earns most of its revenue from higher margin branded spirits, about US$228 million, with another US$142 million from Distillery Solutions supplying bulk alcohol and US$130 million from Ingredient Solutions, which sells specialty starches and proteins to food manufacturers. Investors are watching MGP Ingredients because it mixes premium bourbon and tequila brands with a growing ingredients arm at a time when real wages are under pressure and consumers are becoming choosier rather than simply cutting back.

MGP Ingredients could appeal if you like the idea of a spirits and ingredients business that behaves a bit more like a consumer staple during a squeeze on real wages. The stock screens as attractively valued on P/S and estimated fair value, while analysts see very strong earnings growth ahead. Yet the company is currently loss making, has debt that is not well covered by operating cash flow, and a dividend that is not fully supported by earnings. Add in forecast profitability within three years, fresh leadership hires around its Penelope Bourbon brand, and recent goodwill and asset impairments, and you have a stock where the headline risks may not tell the full story for patient investors.

MGP Ingredients combines premium spirits, ingredients and current losses in a way many investors may be misreading. Get the full picture in the 2 key rewards and 3 important warning signs (2 are major!)

Seeking Alternatives Before The Crowd?

Fresh ideas move fast and early momentum can be gone before it is obvious. Scan under the radar for now, while it matters, and get in early.

• Spot established payouts that may hold up when growth stories wobble by running the 9 dividend fortresses and see which income stocks still look disciplined.
• Chase early momentum in companies building real products around AI by checking the 70 profitable AI stocks that aren't just burning cash and focus on those already producing cash.
• Track potential breakout opportunities in miners tied to long term demand by reviewing the 9 top copper producer stocks and see which producers currently screen as more resilient.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com